|
It was reported that on (b)(6) 2026, a 25-18mm amplatzer talisman pfo occluder was implanted for a patent foramen ovale (pfo) closure procedure.On (b)(6)2026, an echocardiography performed and noted that the device appearing to be located in the right atrium on the atrial side, but seemed actually entrapped in the aortic¿tricuspid trigone.
|
|
An event of a device embolization was reported.Possible causes for device embolization include device over-sizing, device under-sizing or positioning issue due to patient anatomy.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all defined manufacturing specifications.Additionally, the lot was reviewed for similar complaints, and there is no indication of a lot-specific product issue.Based on the available information, the cause for the reported device embolization could not be determined.It is possible that procedural circumstances/ patient's difficulty anatomy contributed to the event, however this cannot be determined.There is no indication of a product quality issue with respect to labeling, design, or manufacturing of the device.
|